Gyros has announced the completion of a development programme initiated to fulfill the requirements of scientists using the company's immunoassay platform in the biopharmaceutical industry.
The development programme has seen the release of a number of software modules and services to augment the company's product portfolio, to provide enhanced functionality for users of Gyrolab XP workstations and to further facilitate the use of the platform in regulated environments.
Software modules, such as the Gyrolab LIMS Interface to enable networking and Gyrolab Control Report to generate non-editable result files of raw data are designed to enable users to upgrade their workstations and retain 21 CFR Part 11 compliance.
Also available is a Gyrolab Functionality Check Kit for the checking of instrument performance.
The company also offers support for Installation Qualification/Operational Qualification (IQ/OQ) and Performance Qualification (PQ) guidance.
Attendees at the recent European Gyrolab Seminar were able to preview the latest release: the Gyrolab Viewer module that enables the binding profile of each data point to be displayed together with sample and run information.
The ability to see and compare individual binding profiles enables users to easily and quickly select optimal reagents during assay development, as well as providing a troubleshooting tool for quality control.
